Study links brain changes to diet and blood markers in Alzheimer’s
Part of Brain & nervous system, Mental health clinical trials.
This study looks at how diet-related and blood “stress” markers relate to how thinking and memory decline over time in people with Alzheimer’s. It may help researchers find useful biomarkers to better track progression and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 55 years
- Be seen at the memory clinic (geriatric unit) at Lyon Sud University Hospital
- You (or your legal representative) must agree to blood/health testing for the study (no refusal)
- Have general social insurance coverage
- Be able to come for follow-up checkups at a day hospital, regular hospital stay, or routine clinic visit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how blood biomarkers relate to thinking, daily function, and survival in older adults, including those with neurological issues or dementia. It aims to improve understanding and care for hospitalized seniors.
This study looks at how “slower movement” and brain changes relate to memory and thinking problems in people with early dementia (and some related conditions). It may help researchers understand what brain differences go with these symptoms, using tests and an MRI scan.
This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.
This study looks at how to better predict and understand Alzheimer's disease by using advanced brain scans and spinal fluid tests. It aims to find ways to identify people who stay healthy longer despite risk factors.
This study supports Alzheimer’s research by collecting health and thinking (cognitive) test results and blood samples to study genetics and biomarkers. You may be enrolled if you’re age 40 or older and can do these checkups, even if you have mild memory problems or dementia.
This study is testing whether a simple blood test can help diagnose Alzheimer's disease and predict how the disease will progress. If you have memory or thinking problems that have been getting worse, you may be able to join.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.